Evidence map›Paper›PMID 14757746›Full record

ArticleThe Journal of experimental medicine2004

GATA-3 in human T cell helper type 2 development.

Alla Skapenko, Jan Leipe, Uwe Niesner, Koen Devriendt, Rolf Beetz, Andreas Radbruch, Joachim R Kalden, Peter E Lipsky, Hendrik Schulze-Koops

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  4. CD4 T Helper Cell Subsets and Related Human Immunological Disorders.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. GATA3 haploinsufficiency does not block allergic sensitization or atopic disease.The Journal of allergy and clinical immunology · 2016
    Article
  12. [Effector T cells].Zeitschrift fur Rheumatologie · 2015
    Review
  13. Article
  14. Transcriptional regulatory networks for CD4 T cell differentiation.Current topics in microbiology and immunology · 2014
    Review
  15. Article
  16. Article
  17. Novel dominant-negative mutant of GATA3 in HDR syndrome.Journal of molecular medicine (Berlin, Germany) · 2011
    Article
  18. Review
  19. Review
  20. TCR-dependent translational control of GATA-3 enhances Th2 differentiation.Journal of immunology (Baltimore, Md. : 1950) · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Alla SkapenkoNikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, 91054, Germany.
Jan Leipe
Uwe Niesner
Koen Devriendt
Rolf Beetz
Andreas Radbruch
Joachim R Kalden
Peter E Lipsky
Hendrik Schulze-Koops
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Rheumatism Research Centre · DEKU Leuven · BENational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The delineation of the in vivo role of GATA-3 in human T cell differentiation is a critical step in the understanding of molecular mechanisms directing human immune responses. We examined T cell differentiation and T cell-mediated effector functions in individuals lacking one functional GATA-3 allele. CD4 T cells from GATA-3+/- individuals expressed significantly reduced levels of GATA-3, associated with markedly decreased T helper cell (Th)2 frequencies in vivo and in vitro. Moreover, Th2 cell-mediated effector functions, as assessed by serum levels of Th2-dependent immunoglobulins (Igs; IgG4, IgE), were dramatically decreased, whereas the Th1-dependent IgG1 was elevated compared with GATA-3+/+ controls. Concordant with these data, silencing of GATA-3 in GATA-3+/+ CD4 T cells with small interfering RNA significantly reduced Th2 cell differentiation. Moreover, GATA-3 mRNA levels increased under Th2-inducing conditions and decreased under Th1-inducing conditions. Taken together, the data strongly suggest that GATA-3 is an important transcription factor in regulating human Th2 cell differentiation in vivo.

Indexed as

AdolescentAdultBase SequenceCD4-Positive T-LymphocytesCell DifferentiationDNA-Binding ProteinsDNA PrimersFemaleGATA3 Transcription FactorHumansMalePolymerase Chain ReactionTh2 CellsTrans-ActivatorsZinc FingersDNA-Binding ProteinsDNA PrimersGATA3 protein, humanGATA3 Transcription FactorTrans-Activators

Identifiers

PMID14757746
PMCPMC2211796
OpenAlexW2145042499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.